Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 37

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 37
---
  $5.5629 |
| Per Share Cash Consideration  |     |                          |    $5.85 |     |    $5.85 |     |  $5.85 |     |  $5.85 |     |  $5.85 |     |   |   $5.85 |     |    $5.85 |
| Implied Value per Share of    |     |                          |          |     |          |     |        |     |        |     |        |     |   |         |     |          |
| ENFN Common Stock             |     |                          | $11.0316 |     |   $11.25 |     | $11.25 |     | $11.25 |     | $11.25 |     |   |  $11.25 |     | $11.4129 |

For each day from the date of the mailing of this Proxy Statement/Prospectus through the Election Deadline, the volume-weighted average price of Clearwater Common Stock for the ten-trading day period ending on (and including) the trading day preceding the date on which Enfusion Stockholders access this information will be available by 4:30 p.m., New York City time, at https://www.investors.clearwateranalytics.com and can also be

18

obtained by contacting Innisfree at the address and telephone number listed in this Proxy Statement/Prospectus. Provided that all conditions to the consummation of the Transactions are satisfied, we expect that the Transactions will close two business days after the Enfusion Stockholders vote to approve the Transactions at the Special Meeting. The Special Meeting(see page 45) Purposes of the Special Meeting At the Special Meeting, Enfusion Stockholders will be asked to vote upon the following proposals:

| • |     | The Merger Agreement Proposal; and |

| • |     | The Adjournment Proposal. |

Record Date The record date for the determination of stockholders entitled to notice of and to vote at the Special Meeting is , 2025. Only Enfusion Stockholders who held shares of record as of the close of business on the record date are entitled to receive notice of and to vote at the Special Meeting and any adjournment or postponement of the Special Meeting, as long as such shares remain outstanding on the date of the Special Meeting. Enfusion’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of